Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 25/03/2013 19392_de.jpg

    SHENC – shear flow regulation of hemostasis

    The first step in closing wounds is the aggregation of the von Willebrand factor glycoprotein with blood platelets, which plugs the hole in the blood vessel and stops blood from leaking out. Using computer simulations and artificial blood vessel experiments, researchers from Mannheim have shown that this aggregation is a reversible process that depends on the shear forces resulting from the flow of the blood. This also prevents the clogging of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/shenc-shear-flow-regulation-of-hemostasis
  • Article - 28/01/2013 19105_de.jpg

    Epigenetics and childhood blood cancer

    Juvenile myelomonocytic leukaemia JMML is the most common chronic cancer of the blood in children and tends to have a poor response to chemotherapy. Prof. Dr. Christian Flotho and his team from the Centre of Paediatric and Adolescent Medicine in Freiburg have shown that epigenetic mechanisms play a key role in the pathogenesis of JMML. As part of a German Research Foundation priority programme the researchers from Freiburg are working on…

    https://www.gesundheitsindustrie-bw.de/en/article/news/epigenetics-and-childhood-blood-cancer
  • Article - 07/08/2013 20000_de.jpg

    New regulations covering the use of laboratory animals

    The new directive of the European Parliament and of the Council on the protection of animals used for scientific purposes was adopted on 22nd September 2010 and was implemented into the German Animal Welfare Act which came into force in February 2013. These regulations have implications for companies and researchers alike. In recent years a growing number of alternative methods to animal testing have been developed. Dr. Nina Hasiwa CEO of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-regulations-covering-the-use-of-laboratory-animals
  • Press release - 15/07/2011 10938_de.jpg

    HITS Participates in a new DFG Research Unit on Blood Coagulation

    Scientists from the Heidelberg Institute for Theoretical Studies participate in a new Research Unit on blood coagulation sponsored by the German Research Foundation (DFG). The aim of the DFG funding is to support a successful existing cooperation between scientists over several years.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hits-participates-in-a-new-dfg-research-unit-on-blood-coagulation
  • Article - 13/05/2008

    Just follow your nose

    Sharks can sense a few drops of blood in water. In fact they are able to smell blood in dilutions of as little as one to 10 billion. Is it just sharks or piranhas that have such an acute sense of smell? The answer is no - all fish have a highly developed sense of smell.

    https://www.gesundheitsindustrie-bw.de/en/article/news/just-follow-your-nose
  • Press release - 17/12/2011 16084_de.jpg

    Rapid identification of blood poisoning

    Does the patient have blood poisoning? In order to find out, the doctor takes a blood sample and sends it to a central laboratory for testing. Valuable time is lost, which could cost the patient his or her life. In future, doctors will be able to analyse blood in their surgery and results will be available within twenty minutes. This is made possible by a biochip developed by scientists at the Fraunhofer Institute for Physical Measurement…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/rapid-identification-of-blood-poisoning
  • Article - 19/05/2009 Immunofluorescent staining reveals a growing artery (cross section, stained green). The dividing nuclei of smooth muscle cells are stained green.

    What makes blood vessels sprout?

    Calcified arteries or capillaries – this is often associated with blood stasis, reduced oxygen supply, and subsequent cardiac strain that compensates these deficiencies. Dr. Sebastian Grundmann from the Department of Cardiology and Angiology at the University Medical Centre Freiburg and his team are investigating how the growth of blood vessels is triggered, and potentially find ways to naturally deviate the site of congestion.

    https://www.gesundheitsindustrie-bw.de/en/article/news/what-makes-blood-vessels-sprout
  • Company profile - 14/07/2016 Schematic showing how the neurostimulator leads to the stimulation of the vagus nerve lowers the blood pressure.

    neuroloop GmbH: how the manipulation of neuronal information can lower blood pressure

    Millions of people worldwide suffer from high blood pressure. However, taking medicines to control high blood pressure does not work for everyone. Dr. Dennis Plachta and Prof. Dr. Thomas Stieglitz from IMTEK have now developed a neurostimulator to control blood pressure. Together with Dr. Michael Lauk, an experienced company founder, the two researchers set up a company called neuroloop, which is funded by Aesculap AG and aims to turn the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/neuroloop-gmbh-how-the-manipulation-of-neuronal-information-can-lower-blood-pressure
  • Article - 11/02/2010 10687_de.jpg

    Johanna Schanz: Liver model as an alternative to animal experiments

    Blood vessels of a piece of pig’s intestine are used as carrier material for the IGB’s liver model and the cells seeded on the blood vessels stem from human biopsies. Dr. Johanna Schanz from the Fraunhofer IGB used this combination to produce her doctoral thesis which led to impressive results: a functional system of blood vessels in a biological carrier structure. Schanz’s outstanding thesis results have led to the creation of a liver model for…

    https://www.gesundheitsindustrie-bw.de/en/article/news/johanna-schanz-liver-model-as-an-alternative-to-animal-experiments
  • Article - 16/04/2019 20190218_Foto_Labor_Quelle_UniversitNatsklinikum_Heidelberg.jpg

    Tumour monitoring using liquid biopsy

    Liquid biopsy, the analysis of cancer biomarkers and circulating tumour cells in body fluids such as blood, is revolutionising the diagnosis and monitoring of cancer. It has also been possible to expand circulating tumour cells from the blood under laboratory conditions. It is expected that in the future, liquid biopsy will be able to precisely characterise tumour cells at every stage of a cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/tumour-monitoring-using-liquid-biopsy
  • Press release - 08/09/2010

    Gene doping detectable with a simple blood test

    Scientists at the universities of Tübingen and Mainz have developed a blood test that is able to provide conclusive proof of gene doping. The test is still effective even if the actual doping took place some time before the test. The new test is based on a procedure developed in Tübingen in 2006 that enables transgenic DNA to be detected in the blood. The efficiency of this procedure has now been proven for the first time in laboratory mice.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-doping-detectable-with-a-simple-blood-test
  • Press release - 07/08/2009 Portrait of Prof. Dr. Christoph Plass

    Silenced genes as a warning sign of blood cancer

    Important growth inhibitors are often switched off in the genetic material of cancer cells by specific chemical DNA modifications. Scientists of the German Cancer Research Centre (Deutsches Krebsforschungszentrum, DKFZ), in collaboration with colleagues from Ohio State University in the United States, have investigated how this happens. They discovered, in mice, that cancer-typical DNA methylation occurs long before the first symptoms of…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/silenced-genes-as-a-warning-sign-of-blood-cancer
  • Article - 25/02/2013 19237_de.jpg

    Molecular monitoring of premature infants

    Premature births are not uncommon in Germany where around seven percent of newborns are born before week 37 of pregnancy. The WHO estimates that the numbers of preterm births are growing due to the increasing age of mothers. Doctors caring for the tiny patients are faced with a dilemma because regular blood samples required for the clinical monitoring of important blood parameters cannot be taken due to the infants low body volume.

    https://www.gesundheitsindustrie-bw.de/en/article/news/molecular-monitoring-of-premature-infants
  • Article - 07/07/2010 Different aspects of the functional and phenotypic regulation of the cells of the vessel wall are studied by the project group A-C of the SFB-TR23.

    Excellent vascular research in Baden-Württemberg

    The fact that the DFG are continuing to fund the only collaborative research centre (SFB, Sonderforschungsbereich) in Germany that is exclusively focused on vascular research underlines the concentrated expertise found in Mannheim and Heidelberg in the field of vascular biology.

    https://www.gesundheitsindustrie-bw.de/en/article/news/excellent-vascular-research-in-baden-wuerttemberg
  • Article - 28/04/2008 From left to right: Dr. Dr. Thomas Luft, patient Bruno Grimm, Professor Dr. Peter Dreger, Head of the Section of Allogeneic Stem Cell Transplantation.

    A milestone in the treatment of leukaemia

    Blood cancer experts in the team of Professor Peter Dreger Head of the Section of Allogeneic Stem Cell Transplantation at the University Hospital of Heidelberg have achieved a major success in the treatment of leukaemia. For the 500th time the physicians from the Department of Haematology Oncology and Rheumatology transferred blood stem cells from a healthy donor to a patient suffering from leukaemia or lymphoma.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/a-milestone-in-the-treatment-of-leukaemia
  • Article - 25/06/2012 17494_de.jpg

    From blood samples to granulate

    The issue of proper nutrition has become more centred on the individual there is growing recognition that nutrition needs to be adapted to an individuals specific way of life and requirements. In cooperation with its subsidiary the Institut für Angewandte Biochemie AG IABC Hepart AG a company based in the city of Kreuzlingen on Lake Constance develops dietary products food to help people lose weight and micronutrient preparations adapted to…

    https://www.gesundheitsindustrie-bw.de/en/article/news/from-blood-samples-to-granulate
  • Article - 23/04/2012 16957_de.jpg

    Vascular grafts: biomolecules to prevent blood vessels from reclosing

    Obstructed blood vessels can be operated on and adequate blood flow restored. However, stents and bypasses are often subject to high reclosure rates. Excessive immune reactions close to where the intervention took place might prevent the regeneration of adjacent vessel walls and even lead to reclosure. New interventions involving RNA interference seem to be a way out of this dilemma.

    https://www.gesundheitsindustrie-bw.de/en/article/news/vascular-grafts-biomolecules-to-prevent-blood-vessels-from-reclosing
  • Article - 18/10/2017 Two people in blue sterile clothing, wearing a face mask and a green hair cover, handling plastic tubes filtering the antibody solution under sterile conditions. Bags containing a red/transparent liquid are shown in the foreground.

    Testing a new antibody therapy for treating blood cancer

    The fight against acute myeloid leukaemia is a long one. Cancer cells that cause the disease to recur may remain despite initially successful destruction of the tumour with chemotherapy drugs. Now researchers from Tübingen have identified an antibody that could potentially prevent cancer recurrence.

    https://www.gesundheitsindustrie-bw.de/en/article/news/testing-a-new-antibody-therapy-for-treating-blood-cancer
  • Article - 03/03/2014 The photo shows a comic illustrating how bacteria enter cells.

    Taking a drug taxi across the blood-brain barrier

    The central nervous system CNS which integrates the information it receives from all parts of the body is perhaps the most sensitive organ we have. As toxic compounds are able to disturb brain function enormously the brain is separated from circulating blood by a highly selective permeability barrier known as the blood-brain barrier. However the downside of this protection is that 98 percent of all drugs targeting the CNS cannot pass the barrier.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/taking-a-drug-taxi-across-the-blood-brain-barrier
  • Press release - 12/03/2009 Haematopoietic stem cells can be best studied in living organisms.

    New strategy for the investigation of haematopoietic stem cells

    With the newly developed mouse model irradiation is no longer required. While the mutation in the growth factor receptor Kit KitWWv weakens the recipients stem cell compartment and makes room for the incoming donor cells the other two mutations are known to prevent rejection of donor haematopoietic stem cells by the recipients immune system. Thus these mice appear to accept all blood stem cells regardless of the mouse strain origin of the…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-strategy-for-the-investigation-of-haematopoietic-stem-cells
  • Article - 27/04/2009 Paradigm change in angiogenesis research

    Interaction mechanisms between tumours and blood vessels

    In recognition of the growing importance of angiogenesis research in the field of oncology the German Research Foundation has established two new research consortia as part of its Angiogenesis research priority programme one project focuses on the mechanisms of vascular differentiation and the second on the interaction between tumour cells and cells of the vascular wall which are prerequisites for tumour growth and metastasis.

    https://www.gesundheitsindustrie-bw.de/en/article/news/interaction-mechanisms-between-tumours-and-blood-vessels
  • Article - 08/08/2017 Group of scientists in the hallway of the institute.

    N2B-patch: circumventing the blood-brain barrier

    There are many medications for treating central nervous system diseases. However, only a fraction of the active pharmaceutical ingredients actually reaches the site where they are needed. The reason for this is the blood-brain barrier that protects the brain and thus prevents many drugs used to treat neurological diseases from effectively penetrating the brain. Researchers from the Fraunhofer Institute for Interfacial Engineering and…

    https://www.gesundheitsindustrie-bw.de/en/article/news/n2b-patch-circumventing-the-blood-brain-barrier
  • Press release - 27/05/2010

    Systems biology helps to understand haematopoiesis

    Following any major blood loss, large amounts of the hormone EPO flood the haematopoietic system in the bone marrow. Scientists from the German Cancer Research Centre (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg and the University of Freiburg have published an article in Science that reveals how a rapid turnover of EPO receptor molecules on haematopoietic cells ensures that the cells maintain their state of readiness. The body can thus…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/systems-biology-helps-to-understand-haematopoiesis
  • Article - 04/07/2011 14640_de.jpg

    The adhesion of cells to the endothelium and to artificial surfaces

    Professor Stefan W. Schneider from the Mannheim Medical Faculty is investigating the function of the vascular endothelium and its interaction with blood and tumour cells using microfluidics methods that enable him to measure the adhesion of cells to the walls of blood vessels under physiological flow conditions. As part of an interdisciplinary project, he is investigating the characteristics of wafer-thin surfaces covered with living cells, which…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-adhesion-of-cells-to-the-endothelium-and-to-artificial-surfaces
  • Article - 21/04/2008

    Human blood system in mice

    Scientists from Mannheim Heidelberg an Freiburg working together in the cooperative research area Vascular Biology have developed a method that can be used to create a human vascular system in mice which stays functional even after several months.

    https://www.gesundheitsindustrie-bw.de/en/article/news/human-blood-system-in-mice

Page 1 / 16

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 16
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search